“Individuals reported improvements in overall PTSD symptom severity 30 and 70 days after initiating MMJ [medical marijuana] … Moreover, they reported reductions in negative affect and improvements in overall well-being. These findings suggest that MMJ use may be associated with clinical benefits in people with PTSD.”
The legislation provides a temporary five-year “safe harbor” in which veterans will not be punished for state-legal cannabis use and VA doctors will be able to officially recommend medical cannabis in accordance with state laws. The VA would also be mandated to study the potential benefits of cannabis for veterans to treat pain, PTSD, and other conditions.
It is time for Gov. Carney to acknowledge and support the majority of Delawareans who back cannabis legalization in the First State.
Recently conducted observational trials in Israel and the United Kingdom have documented improved symptoms following the use of cannabis products among patients with post-traumatic stress. These outcomes include statistically significant changes in sleep quality and in anxiety, fewer nightmares, and improved quality of life.
The vote marks the seventh time that House members have advanced this language to the Senate as either an amendment or as a stand-alone bill.
Presently, V.A. doctors are forbidden from providing the paperwork necessary to complete a recommendation, thus forcing military veterans to seek the advice of a private, out-of-network physician.
“This study provides evidence that the types of cannabis available in recreational and medical cannabis dispensaries might hold promise as an alternative treatment for PTSD. … This study’s primary outcome supports the theory that cannabis should be [tested in clinical trials] as a potential therapeutic for PTSD.”
“Current or ever use of cannabis for menopause symptom management was reported by 27 percent of all participants, while an additional 10 percent expressed interest in future use.”